methylphenidate has been researched along with Heart Valve Diseases in 3 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
Heart Valve Diseases: Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).
| Excerpt | Relevance | Reference |
|---|---|---|
| " Is this also the case with methylphenidate, an amphetamine-like psychostimulant used in attention-deficit hyperactivity disorder (especially in children) and also in narcolepsy? Cases of pulmonary hypertension and heart valve disease have been reported with methylphenidate, including in children." | 7.81 | Methylphenidate: pulmonary hypertension and heart valve disease. ( , 2015) |
| " Is this also the case with methylphenidate, an amphetamine-like psychostimulant used in attention-deficit hyperactivity disorder (especially in children) and also in narcolepsy? Cases of pulmonary hypertension and heart valve disease have been reported with methylphenidate, including in children." | 3.81 | Methylphenidate: pulmonary hypertension and heart valve disease. ( , 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Saiz, LC | 1 |
| Gil, M | 1 |
| Alonso, A | 1 |
| Erviti, J | 1 |
| Garjón, J | 1 |
| Martínez, M | 1 |
| Hahn, HH | 1 |
| Schweid, AI | 1 |
| Beaty, HN | 1 |
3 other studies available for methylphenidate and Heart Valve Diseases
| Article | Year |
|---|---|
Use of methylphenidate and risk for valvular heart disease: A case-control study nested in the BIFAP cohort.
Topics: Adolescent; Case-Control Studies; Child; Child, Preschool; Cohort Studies; Databases, Factual; Gener | 2020 |
Methylphenidate: pulmonary hypertension and heart valve disease.
Topics: Age Factors; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Heart | 2015 |
Complications of injecting dissolved methylphenidate tablets.
Topics: Biopsy; Drug Eruptions; Endocarditis, Bacterial; Foreign Bodies; Heart Valve Diseases; Injections, I | 1969 |